Traditional herbal management of sickle cell anemia: lessons from Nigeria [0.03%]
尼日利亚传统草药管理镰状细胞贫血的经验教训
Sunday J Ameh,Florence D Tarfa,Benjamin U Ebeshi
Sunday J Ameh
Background. Patients in West Africa where sickle cell anemia (SCA) is endemic have for ages been treated with natural products, especially herbs, as, is still the case in rural communities. Objective. In this paper we look closely at some o...
Relationship between Plasma Ferritin Level and Siderocyte Number in Splenectomized β-Thalassemia/HbE Patients [0.03%]
脾切除β-地中海贫血/血红蛋白E患者的血浆溶菌酶水平与 siderocyte数量的关系
A Tripatara,N Srichana,P Lamool et al.
A Tripatara et al.
Introduction. In iron overload status, excess iron deposits in reticuloendothelial cells and tissues and can be detected using Prussian blue staining. The aim of this paper was to investigate the relationship between siderocyte numbers and ...
Antonio Macciò,Clelia Madeddu
Antonio Macciò
Anemia of any degree is recognized as a significant independent contributor to morbidity, mortality, and frailty in elderly patients. Among the broad types of anemia in the elderly a peculiar role seems to be played by the anemia associated...
Laura E Hays,Stefan Meyer,Henri J van de Vrugt
Laura E Hays
β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life [0.03%]
地中海贫血：新的治疗模式、遗传学、并发症和生活质量提升方法
Mehran Karimi,Sezaneh Haghpanah,Ali T Taher et al.
Mehran Karimi et al.
Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials [0.03%]
硫酸亚铁缓释片治疗我国南方缺铁性贫血的疗效观察
Charles F Barish,Todd Koch,Angelia Butcher et al.
Charles F Barish et al.
Background. Iron deficiency anemia (IDA) is a common hematological complication with potentially serious clinical consequences that may require intravenous iron therapy. Ferric carboxymaltose (FCM) is a stable, nondextran iron formulation a...
Rukmini B Govekar,Poonam D Kawle,Suresh H Advani et al.
Rukmini B Govekar et al.
The molecular mechanism mediating expression of senescent cell antigen-aggregated or cleaved band 3 and externalized phosphatidylserine (PS) on the surface of aged erythrocytes and their premature expression in certain anemias is not comple...
Sickle cell disease: genetics, cellular and molecular mechanisms, and therapies [0.03%]
镰状细胞病：遗传、细胞和分子机制及治疗方法
Betty S Pace,Solomon F Ofori-Acquah,Kenneth R Peterson
Betty S Pace
An Epidemiological Study of Anemia and Renal Dysfunction in Patients Admitted to ICUs across the United States [0.03%]
美国重症监护病房患者贫血和肾功能不全的流行病学研究
Donald F Brophy,Spencer E Harpe,Daniel E Carl et al.
Donald F Brophy et al.
The aims of this study were to determine the associations between anemia of critical illness, erythropoietin stimulating agents (ESA), packed red blood cell transfusions and varying degrees of renal dysfunction with mortality, and ICU- and ...
Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial [0.03%]
去铁闭索䂹治疗β型地中海贫血和骨髓增生异常综合征合并铁过载患者的健康相关生活质量、治疗满意度、依从性和持续性：一项名为EPIC的临床试验结果
John Porter,Donald K Bowden,Marina Economou et al.
John Porter et al.
Treatment of iron overload using deferoxamine (DFO) is associated with significant deficits in patients' health-related quality of life (HRQOL) and low treatment satisfaction. The current article presents patient-reported HRQOL, satisfactio...